CAVANAUGH JAMES H
Insider CIK 1013473 · VRNM Director · GBIM 10% owner · TLOG 10% owner · TRVN 10% owner · PTI 10% owner · LPTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise deriv | 2026-03-13 | 2026-03-17 | 74,700 | — | $0 | 0 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise deriv | 2026-03-13 | 2026-03-17 | 94,050 | — | $0 | 0 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise | 2026-03-13 | 2026-03-17 | 94,050 | — | $0 | 168,963 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | M Exercise | 2026-03-13 | 2026-03-17 | 74,700 | — | $0 | 74,913 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | A Award deriv | 2025-12-23 | 2025-12-30 | 94,050 | — | $0 | 94,050 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | S Sale | 2025-11-17 | 2025-11-19 | 261,840 | $3.14 | $822.2K | 0 | SEC↗ |
| CYPH CYPHERPUNK TECHNOLOGIES IN | A Award deriv | 2025-11-11 | 2025-11-13 | 74,700 | — | $0 | 74,700 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | X Exercise deriv | 2024-11-13 | 2024-11-15 | 213 | — | $0 | 0 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | X Exercise | 2024-11-13 | 2024-11-15 | 213 | $2.82 | $601 | 213 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2024-10-02 | 2024-10-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2024-01-29 | 2024-01-31 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2023-08-23 | 2023-08-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2023-03-31 | 2023-04-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2022-09-01 | 2022-09-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2022-01-31 | 2022-02-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | J Other deriv | 2021-02-09 | 2021-02-11 | 1,154 | — | $0 | 1,154 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2021-01-04 | 2021-01-06 | 32,300 | — | $0 | 32,300 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2020-08-10 | 2020-08-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2020-04-09 | 2020-04-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2020-03-02 | 2020-03-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2019-06-11 | 2019-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2019-01-01 | 2019-01-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | J Other deriv | 2018-07-30 | 2018-08-01 | 2,137 | — | $0 | 2,137 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2018-04-18 | 2018-04-20 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2017-01-23 | 2017-01-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2017-01-23 | 2017-01-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-19 | 2016-02-19 | 5,000 | $1.39 | $6.9K | 554,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-18 | 2016-02-19 | 5,000 | $1.40 | $7.0K | 559,267 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 2,319,750 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | J Other deriv | 2016-02-17 | 2016-02-17 | 160,000 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | J Other deriv | 2016-02-17 | 2016-02-17 | 14,800 | — | $0 | 14,800 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion deriv | 2016-02-17 | 2016-02-17 | 11,600,000 | — | $0 | 0 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | P Buy | 2016-02-17 | 2016-02-17 | 375,000 | $8.00 | $3.00M | 2,149,295 | SEC↗ |
| PTI PROTEOSTASIS THERAPEUTICS, | C Conversion | 2016-02-17 | 2016-02-17 | 1,774,295 | — | $0 | 1,774,295 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-17 | 2016-02-19 | 5,000 | $1.53 | $7.7K | 564,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-16 | 2016-02-16 | 5,000 | $1.51 | $7.5K | 569,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-12 | 2016-02-16 | 5,000 | $1.59 | $8.0K | 574,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | S Sale | 2016-02-11 | 2016-02-16 | 5,000 | $1.72 | $8.6K | 579,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 2,528,000 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 5,904,335 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 3,879,015 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion deriv | 2014-07-08 | 2014-07-08 | 64,809 | — | $0 | 0 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 80,533 | — | $0 | 80,533 | SEC↗ |
| GBIM GLOBEIMMUNE INC | P Buy | 2014-07-08 | 2014-07-08 | 190,000 | $10.00 | $1.90M | 584,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 2,064 | — | $0 | 394,267 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 123,574 | — | $0 | 392,203 | SEC↗ |
| GBIM GLOBEIMMUNE INC | C Conversion | 2014-07-08 | 2014-07-08 | 188,096 | — | $0 | 268,629 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 4,200,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 3,125,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-02-05 | 2014-02-07 | 297,058 | $7.00 | $2.08M | 2,446,251 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 967,741 | — | $0 | 967,741 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 504,033 | — | $0 | 2,149,193 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 677,419 | — | $0 | 1,645,160 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-17 | 8,603,477 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-17 | 0 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-17 | 5,000,000 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-17 | 0 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-17 | 7,453,704 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-17 | 267,535 | $7.00 | $1.87M | 1,873,003 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-17 | 653,594 | — | $0 | 653,594 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-17 | 713,463 | $7.00 | $4.99M | 2,586,466 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-17 | 7,335 | $6.40 | $46.9K | 1,605,468 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-17 | 506,086 | — | $0 | 1,598,133 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-17 | 438,453 | — | $0 | 1,092,047 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 6,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 6,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 2,313 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 6,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 16,084 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 603 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer | 2013-10-31 | 2013-11-04 | 187,305 | $4.00 | $749.2K | 0 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2013-06-17 | 2013-06-25 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2012-06-21 | 2012-06-25 | 6,000 | — | $0 | 6,000 | SEC↗ |